Rani Therapeutics Holdings (RANI) Revenue (2020 - 2026)

Rani Therapeutics Holdings has reported Revenue for 5 years, with the latest figure at $1.7 million in Q2 2026.

• On a quarterly basis, Revenue changed N/A year-over-year to $1.7 million in Q2 2026; TTM through Jun 2026 was $4.9 million, a 306.42% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 58.85% from the prior year.
• Revenue was $1.7 million for Q2 2026 at Rani Therapeutics Holdings, roughly flat from $1.7 million in the prior quarter.
• The five-year high for Revenue was $1.7 million in Q1 2026, with the low at $172000.0 in Q1 2025.
• Average Revenue over 3 years is $1.2 million, with a median of $1.5 million recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Revenue surged 42.12% in 2025, then jumped 893.02% in 2026.
• Over 3 years, Revenue stood at $1.0 million in 2024, then soared by 42.12% to $1.5 million in 2025, then gained by 16.91% to $1.7 million in 2026.
• The last three Revenue figures came in at $1.7 million (Q2 2026), $1.7 million (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.